Skip to main navigation Skip to search Skip to main content

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 (Protein & Cell, (2020), 11, 10, (723-739), 10.1007/s13238-020-00768-w)

  • Rui Xiong
  • , Leike Zhang
  • , Shiliang Li
  • , Yuan Sun
  • , Minyi Ding
  • , Yong Wang
  • , Yongliang Zhao
  • , Yan Wu
  • , Weijuan Shang
  • , Xiaming Jiang
  • , Jiwei Shan
  • , Zihao Shen
  • , Yi Tong
  • , Liuxin Xu
  • , Yu Chen
  • , Yingle Liu
  • , Gang Zou
  • , Dimitri Lavillette
  • , Zhenjiang Zhao
  • , Rui Wang
  • Lili Zhu, Gengfu Xiao, Ke Lan, Honglin Li*, Ke Xu*
*Corresponding author for this work
  • East China University of Science and Technology
  • CAS - Wuhan Institute of Virology
  • Wuhan University
  • CAS - Institut Pasteur of Shanghai

Research output: Contribution to journalComment/debate

Abstract

In the original publication the author’s name ‘Dimitri Lavillete’ is published incorrectly. The correct author name should be spelt as ‘Dimitri Lavillette’ is provided in this correction.

Original languageEnglish
Pages (from-to)778
Number of pages1
JournalProtein and Cell
Volume13
Issue number10
DOIs
StatePublished - Oct 2022
Externally publishedYes

Fingerprint

Dive into the research topics of 'Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 (Protein & Cell, (2020), 11, 10, (723-739), 10.1007/s13238-020-00768-w)'. Together they form a unique fingerprint.

Cite this